Drugs / DRV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01968551 Background | Sep 2013 → Jul 2015 | AIDS | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DRV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01968551 ↗ |
| Route | Oral | “800 mg tablet administered orally once daily” NCT01968551 ↗ |